Go Pro

Shannon O'Callaghan Analyst Performance

Analyst at Morgan Stanley

Shannon O'Callaghan is a stock analyst at Morgan Stanley focused in the industrials sector, covering 8 publicly traded companies. Over the past year, Shannon O'Callaghan has issued 2 stock ratings, including and buy recommendations. While full access to Shannon O'Callaghan's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Shannon O'Callaghan's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
16 Last 10 Years
Buy Recommendations
68.75% 11 Buy Ratings
Companies Covered
8 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy68.8%11 ratings
Hold18.8%3 ratings
Sell12.5%2 ratings

Out of 16 total stock ratings issued by Shannon O'Callaghan at Morgan Stanley, the majority (68.8%) have been Buy recommendations, followed by 18.8% Hold and 12.5% Sell.

Exchange Coverage

ExchangePercentageCount
NYSE
75.0% of companies on NYSE
6 companies
NASDAQ
25.0% of companies on NASDAQ
2 companies

Shannon O'Callaghan, an analyst at Morgan Stanley, currently covers 8 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Industrials
7 companies
87.5%
Healthcare
1 company
12.5%

Shannon O'Callaghan of Morgan Stanley specializes in stock coverage within the Industrials sector, with additional focus on Healthcare companies.

Coverage Industries

IndustryPercentage
MACHINERY
3 companies
37.5%
HEALTHCARE PROVIDERS & SERVICES
1 company
12.5%
AEROSPACE & DEFENSE
1 company
12.5%
TRADING COMPANIES & DISTRIBUTORS
1 company
12.5%
INDUSTRIAL CONGLOMERATES
1 company
12.5%
ELECTRICAL EQUIPMENT
1 company
12.5%

Shannon O'Callaghan's Ratings History at Morgan Stanley

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Guardant Health, Inc. stock logo
GH
Guardant Health
8/4/2026Boost Price Target$158.83$185.00Overweight
Guardant Health, Inc. stock logo
GH
Guardant Health
7/9/2026Boost Price Target$156.17$175.00Overweight
Guardant Health, Inc. stock logo
GH
Guardant Health
3/6/2025Boost Price Target$41.02$52.00Overweight